# ğŸ¥ BioPanel AI â€” MVP í”„ë¡œì íŠ¸ êµ¬ì¡° ì„¤ê³„ì„œ

> ì˜ë£ŒÂ·ë°”ì´ì˜¤Â·í—¬ìŠ¤ì¼€ì–´ íŠ¹í™” AI ì‹¬ì‚¬ì—­ í† ë¡  í”Œë«í¼

---

## 1. í”„ë¡œì íŠ¸ ê°œìš”

### í•µì‹¬ ê°€ì¹˜
ì‚¬ìš©ìê°€ ë°”ì´ì˜¤/í—¬ìŠ¤ì¼€ì–´ ê¸°ì—…ëª…ì„ ì…ë ¥í•˜ë©´, 5ëª…ì˜ AI ì „ë¬¸ê°€ íŒ¨ë„ì´ ì‹¤ì‹œê°„ìœ¼ë¡œ í•´ë‹¹ ê¸°ì—…ì„ ë¶„ì„í•˜ê³  í† ë¡ í•˜ì—¬ íˆ¬ì/ì‚¬ì—…ì„± ì‹¬ì‚¬ ë¦¬í¬íŠ¸ë¥¼ ìƒì„±í•œë‹¤.

### MVP ìŠ¤ì½”í”„ (v0.1)
- âœ… ê¸°ì—…ëª… ì…ë ¥ â†’ 5ëª… ì—ì´ì „íŠ¸ ìˆœì°¨ ë¶„ì„ â†’ ì‹¤ì‹œê°„ í† ë¡  ìŠ¤íŠ¸ë¦¬ë°
- âœ… êµ¬ì¡°í™”ëœ ìµœì¢… ë¦¬í¬íŠ¸ (ì •ëŸ‰ í‰ê°€ í¬í•¨)
- âœ… ë¶„ì„ ì´ë ¥ ì €ì¥ ë° ì¡°íšŒ
- âœ… ì‚¬ìš©ì ì¸ì¦ (Google ë¡œê·¸ì¸)
- âœ… ì‹¤ì œ ì „ë¬¸ê°€ í”„ë¡œí•„ ì—´ëŒ + ê°œë³„ ìƒë‹´ ìš”ì²­ (ìœ ë£Œ ì „ë¬¸ê°€ ì—°ê²°)
- âœ… ì™„ì „ ë¬´ë£Œ ì„œë¹„ìŠ¤ (AI ë¶„ì„)
- â¬œ ì»¤ìŠ¤í…€ ë°ì´í„° ì—…ë¡œë“œ (v0.2)
- â¬œ Knowledge Graph (v0.3)

---

## 2. ê¸°ìˆ  ìŠ¤íƒ

```
Frontend:    Next.js 14 (App Router) + TypeScript + Tailwind CSS
ë°°í¬:         Vercel
ì¸ì¦:         Firebase Auth (Google OAuth)
DB:          Cloud Firestore
ì„œë²„ ë¡œì§:    Cloud Functions 2nd Gen (ë˜ëŠ” Cloud Run)
AI ì—”ì§„:     Anthropic Claude API (Sonnet 4)
ì‹¤ì‹œê°„:       Firestore onSnapshot (ì‹¤ì‹œê°„ í† ë¡  ìŠ¤íŠ¸ë¦¬ë°)
ì™¸ë¶€ ë°ì´í„°:  ClinicalTrials.gov API, PubMed API, SEC EDGAR
```

---

## 3. í´ë” êµ¬ì¡°

```
biopanel-ai/
â”œâ”€â”€ public/
â”‚   â”œâ”€â”€ agents/                    # ì—ì´ì „íŠ¸ ì•„ë°”íƒ€ ì´ë¯¸ì§€
â”‚   â”‚   â”œâ”€â”€ oncologist.png
â”‚   â”‚   â”œâ”€â”€ pharmacist.png
â”‚   â”‚   â”œâ”€â”€ analyst.png
â”‚   â”‚   â”œâ”€â”€ regulatory.png
â”‚   â”‚   â””â”€â”€ immunologist.png
â”‚   â””â”€â”€ logo.svg
â”‚
â”œâ”€â”€ src/
â”‚   â”œâ”€â”€ app/                       # Next.js App Router
â”‚   â”‚   â”œâ”€â”€ layout.tsx             # ë£¨íŠ¸ ë ˆì´ì•„ì›ƒ
â”‚   â”‚   â”œâ”€â”€ page.tsx               # ëœë”©/í™ˆ
â”‚   â”‚   â”œâ”€â”€ globals.css
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ (auth)/                # ì¸ì¦ ê´€ë ¨ ë¼ìš°íŠ¸
â”‚   â”‚   â”‚   â”œâ”€â”€ login/page.tsx
â”‚   â”‚   â”‚   â””â”€â”€ layout.tsx
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ dashboard/             # ëŒ€ì‹œë³´ë“œ (ë¶„ì„ ì´ë ¥)
â”‚   â”‚   â”‚   â””â”€â”€ page.tsx
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ analysis/              # ë¶„ì„ ì„¸ì…˜
â”‚   â”‚   â”‚   â”œâ”€â”€ new/page.tsx       # ìƒˆ ë¶„ì„ ì‹œì‘
â”‚   â”‚   â”‚   â””â”€â”€ [sessionId]/
â”‚   â”‚   â”‚       â”œâ”€â”€ page.tsx       # ì‹¤ì‹œê°„ í† ë¡  ë·°
â”‚   â”‚   â”‚       â””â”€â”€ report/page.tsx # ìµœì¢… ë¦¬í¬íŠ¸ ë·°
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ experts/               # â­ ì‹¤ì œ ì „ë¬¸ê°€ ì—°ê²°
â”‚   â”‚   â”‚   â”œâ”€â”€ page.tsx           # ì „ë¬¸ê°€ ëª©ë¡/ê²€ìƒ‰
â”‚   â”‚   â”‚   â””â”€â”€ [expertId]/
â”‚   â”‚   â”‚       â”œâ”€â”€ page.tsx       # ì „ë¬¸ê°€ í”„ë¡œí•„ ìƒì„¸
â”‚   â”‚   â”‚       â””â”€â”€ request/page.tsx # ìƒë‹´ ìš”ì²­ í¼
â”‚   â”‚   â”‚
â”‚   â”‚   â””â”€â”€ api/                   # Next.js API Routes (ê²½ëŸ‰ í”„ë¡ì‹œ)
â”‚   â”‚       â”œâ”€â”€ analysis/
â”‚   â”‚       â”‚   â””â”€â”€ start/route.ts # ë¶„ì„ ì‹œì‘ íŠ¸ë¦¬ê±°
â”‚   â”‚       â”œâ”€â”€ experts/
â”‚   â”‚       â”‚   â”œâ”€â”€ list/route.ts  # ì „ë¬¸ê°€ ëª©ë¡ ì¡°íšŒ
â”‚   â”‚       â”‚   â””â”€â”€ request/route.ts # ìƒë‹´ ìš”ì²­ ì „ì†¡
â”‚   â”‚       â””â”€â”€ webhook/
â”‚   â”‚           â””â”€â”€ route.ts       # Cloud Functions ì½œë°±
â”‚   â”‚
â”‚   â”œâ”€â”€ components/
â”‚   â”‚   â”œâ”€â”€ ui/                    # ê³µí†µ UI ì»´í¬ë„ŒíŠ¸
â”‚   â”‚   â”‚   â”œâ”€â”€ Button.tsx
â”‚   â”‚   â”‚   â”œâ”€â”€ Card.tsx
â”‚   â”‚   â”‚   â”œâ”€â”€ Badge.tsx
â”‚   â”‚   â”‚   â”œâ”€â”€ LoadingSpinner.tsx
â”‚   â”‚   â”‚   â”œâ”€â”€ HeatMap.tsx        # ë¦¬ìŠ¤í¬ íˆíŠ¸ë§µ
â”‚   â”‚   â”‚   â””â”€â”€ ScoreGauge.tsx     # ì ìˆ˜ ê²Œì´ì§€
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ analysis/              # ë¶„ì„ ê´€ë ¨ ì»´í¬ë„ŒíŠ¸
â”‚   â”‚   â”‚   â”œâ”€â”€ CompanyInput.tsx         # ê¸°ì—… ê²€ìƒ‰/ì…ë ¥
â”‚   â”‚   â”‚   â”œâ”€â”€ AnalysisConfig.tsx       # ë¶„ì„ ì„¤ì • (ì‹¬í™” ì˜µì…˜)
â”‚   â”‚   â”‚   â”œâ”€â”€ DebateTimeline.tsx       # í† ë¡  íƒ€ì„ë¼ì¸ (ë©”ì¸ ë·°)
â”‚   â”‚   â”‚   â”œâ”€â”€ AgentMessage.tsx         # ê°œë³„ ì—ì´ì „íŠ¸ ë°œì–¸ ë²„ë¸”
â”‚   â”‚   â”‚   â”œâ”€â”€ AgentAvatar.tsx          # ì—ì´ì „íŠ¸ í”„ë¡œí•„ ì¹´ë“œ
â”‚   â”‚   â”‚   â”œâ”€â”€ ConflictHighlight.tsx    # ì˜ê²¬ ì¶©ëŒ í•˜ì´ë¼ì´íŠ¸
â”‚   â”‚   â”‚   â””â”€â”€ LiveIndicator.tsx        # ì‹¤ì‹œê°„ ë¶„ì„ ì¤‘ í‘œì‹œ
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ report/                # ë¦¬í¬íŠ¸ ê´€ë ¨ ì»´í¬ë„ŒíŠ¸
â”‚   â”‚   â”‚   â”œâ”€â”€ ExecutiveSummary.tsx     # ì¢…í•© ìš”ì•½
â”‚   â”‚   â”‚   â”œâ”€â”€ PipelineTable.tsx        # íŒŒì´í”„ë¼ì¸ ë°¸ë¥˜ì—ì´ì…˜
â”‚   â”‚   â”‚   â”œâ”€â”€ RiskHeatMap.tsx          # ë¦¬ìŠ¤í¬ íˆíŠ¸ë§µ
â”‚   â”‚   â”‚   â”œâ”€â”€ CompetitorMatrix.tsx     # ê²½ìŸ êµ¬ë„ ë§¤íŠ¸ë¦­ìŠ¤
â”‚   â”‚   â”‚   â”œâ”€â”€ ConsensusView.tsx        # í•©ì˜/ë¹„í•©ì˜ ë·°
â”‚   â”‚   â”‚   â””â”€â”€ AgentVerdictCard.tsx     # ì—ì´ì „íŠ¸ë³„ ìµœì¢… ì˜ê²¬
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ experts/               # â­ ì‹¤ì œ ì „ë¬¸ê°€ ì—°ê²°
â”‚   â”‚   â”‚   â”œâ”€â”€ ExpertCard.tsx           # ì „ë¬¸ê°€ ì¹´ë“œ (ëª©ë¡ìš©)
â”‚   â”‚   â”‚   â”œâ”€â”€ ExpertProfile.tsx        # ì „ë¬¸ê°€ ìƒì„¸ í”„ë¡œí•„
â”‚   â”‚   â”‚   â”œâ”€â”€ ExpertFilter.tsx         # ë¶„ì•¼ë³„ í•„í„°
â”‚   â”‚   â”‚   â”œâ”€â”€ ConsultRequestForm.tsx   # ìƒë‹´ ìš”ì²­ í¼
â”‚   â”‚   â”‚   â”œâ”€â”€ ConsultRequestModal.tsx  # ë¦¬í¬íŠ¸ ë‚´ ìƒë‹´ ìš”ì²­ ëª¨ë‹¬
â”‚   â”‚   â”‚   â””â”€â”€ ExpertBadge.tsx          # ì „ë¬¸ë¶„ì•¼ ë±ƒì§€
â”‚   â”‚   â”‚
â”‚   â”‚   â””â”€â”€ layout/                # ë ˆì´ì•„ì›ƒ ì»´í¬ë„ŒíŠ¸
â”‚   â”‚       â”œâ”€â”€ Header.tsx
â”‚   â”‚       â”œâ”€â”€ Sidebar.tsx
â”‚   â”‚       â””â”€â”€ Footer.tsx
â”‚   â”‚
â”‚   â”œâ”€â”€ lib/                       # í•µì‹¬ ë¼ì´ë¸ŒëŸ¬ë¦¬
â”‚   â”‚   â”œâ”€â”€ firebase/
â”‚   â”‚   â”‚   â”œâ”€â”€ config.ts          # Firebase ì´ˆê¸°í™”
â”‚   â”‚   â”‚   â”œâ”€â”€ auth.ts            # Auth í—¬í¼
â”‚   â”‚   â”‚   â”œâ”€â”€ firestore.ts       # Firestore í—¬í¼
â”‚   â”‚   â”‚   â””â”€â”€ admin.ts           # Admin SDK (ì„œë²„ìš©)
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ agents/                # â­ ì—ì´ì „íŠ¸ ì‹œìŠ¤í…œ (í•µì‹¬)
â”‚   â”‚   â”‚   â”œâ”€â”€ types.ts           # ì—ì´ì „íŠ¸ íƒ€ì… ì •ì˜
â”‚   â”‚   â”‚   â”œâ”€â”€ registry.ts        # ì—ì´ì „íŠ¸ ë ˆì§€ìŠ¤íŠ¸ë¦¬
â”‚   â”‚   â”‚   â”œâ”€â”€ orchestrator.ts    # í† ë¡  ì˜¤ì¼€ìŠ¤íŠ¸ë ˆì´í„°
â”‚   â”‚   â”‚   â”œâ”€â”€ conflict-detector.ts  # ì˜ê²¬ ì¶©ëŒ ê°ì§€
â”‚   â”‚   â”‚   â”œâ”€â”€ prompts/           # â­ ì—ì´ì „íŠ¸ë³„ í”„ë¡¬í”„íŠ¸
â”‚   â”‚   â”‚   â”‚   â”œâ”€â”€ base.ts        # ê³µí†µ ë² ì´ìŠ¤ í”„ë¡¬í”„íŠ¸
â”‚   â”‚   â”‚   â”‚   â”œâ”€â”€ oncologist.ts  # ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜
â”‚   â”‚   â”‚   â”‚   â”œâ”€â”€ pharmacist.ts  # ì•½ì‚¬/ì•½ë¬¼ê²½ì œí•™ì
â”‚   â”‚   â”‚   â”‚   â”œâ”€â”€ analyst.ts     # ë°”ì´ì˜¤ ì• ë„ë¦¬ìŠ¤íŠ¸
â”‚   â”‚   â”‚   â”‚   â”œâ”€â”€ regulatory.ts  # ê·œì œ ì „ë¬¸ê°€
â”‚   â”‚   â”‚   â”‚   â””â”€â”€ immunologist.ts # ë©´ì—­í•™ ì „ë¬¸ì˜
â”‚   â”‚   â”‚   â””â”€â”€ evaluation/        # â­ í‰ê°€ í”„ë ˆì„ì›Œí¬
â”‚   â”‚   â”‚       â”œâ”€â”€ rubrics.ts     # ì •ëŸ‰ í‰ê°€ ê¸°ì¤€í‘œ
â”‚   â”‚   â”‚       â”œâ”€â”€ scoring.ts     # ì ìˆ˜ ì‚°ì¶œ ë¡œì§
â”‚   â”‚   â”‚       â””â”€â”€ synthesis.ts   # ì¢…í•© ë¦¬í¬íŠ¸ ìƒì„±
â”‚   â”‚   â”‚
â”‚   â”‚   â”œâ”€â”€ data/                  # ì™¸ë¶€ ë°ì´í„° ìˆ˜ì§‘
â”‚   â”‚   â”‚   â”œâ”€â”€ clinical-trials.ts # ClinicalTrials.gov API
â”‚   â”‚   â”‚   â”œâ”€â”€ pubmed.ts          # PubMed API
â”‚   â”‚   â”‚   â”œâ”€â”€ sec-edgar.ts       # SEC EDGAR API
â”‚   â”‚   â”‚   â””â”€â”€ company-info.ts    # ê¸°ì—… ê¸°ë³¸ ì •ë³´ ìˆ˜ì§‘
â”‚   â”‚   â”‚
â”‚   â”‚   â””â”€â”€ utils/
â”‚   â”‚       â”œâ”€â”€ claude.ts          # Claude API ë˜í¼
â”‚   â”‚       â”œâ”€â”€ stream.ts          # ìŠ¤íŠ¸ë¦¬ë° ìœ í‹¸
â”‚   â”‚       â””â”€â”€ format.ts          # í¬ë§· ìœ í‹¸
â”‚   â”‚
â”‚   â”œâ”€â”€ hooks/                     # React Hooks
â”‚   â”‚   â”œâ”€â”€ useAuth.ts
â”‚   â”‚   â”œâ”€â”€ useAnalysis.ts         # ë¶„ì„ ì„¸ì…˜ ê´€ë¦¬
â”‚   â”‚   â”œâ”€â”€ useDebateStream.ts     # ì‹¤ì‹œê°„ í† ë¡  êµ¬ë…
â”‚   â”‚   â”œâ”€â”€ useReport.ts           # ë¦¬í¬íŠ¸ ë°ì´í„°
â”‚   â”‚   â”œâ”€â”€ useExperts.ts          # ì „ë¬¸ê°€ ëª©ë¡/í•„í„°
â”‚   â”‚   â””â”€â”€ useConsultRequest.ts   # ìƒë‹´ ìš”ì²­ ê´€ë¦¬
â”‚   â”‚
â”‚   â”œâ”€â”€ stores/                    # ìƒíƒœ ê´€ë¦¬ (Zustand)
â”‚   â”‚   â”œâ”€â”€ authStore.ts
â”‚   â”‚   â””â”€â”€ analysisStore.ts
â”‚   â”‚
â”‚   â””â”€â”€ types/                     # ì „ì—­ íƒ€ì…
â”‚       â”œâ”€â”€ agent.ts
â”‚       â”œâ”€â”€ analysis.ts
â”‚       â”œâ”€â”€ company.ts
â”‚       â”œâ”€â”€ report.ts
â”‚       â””â”€â”€ expert.ts              # ì „ë¬¸ê°€ & ìƒë‹´ ìš”ì²­ íƒ€ì…
â”‚
â”œâ”€â”€ functions/                     # â­ Firebase Cloud Functions
â”‚   â”œâ”€â”€ src/
â”‚   â”‚   â”œâ”€â”€ index.ts               # Functions ì—”íŠ¸ë¦¬
â”‚   â”‚   â”œâ”€â”€ orchestrate.ts         # ë©”ì¸ ì˜¤ì¼€ìŠ¤íŠ¸ë ˆì´ì…˜ ë¡œì§
â”‚   â”‚   â”œâ”€â”€ agents/
â”‚   â”‚   â”‚   â”œâ”€â”€ runner.ts          # ì—ì´ì „íŠ¸ ì‹¤í–‰ê¸°
â”‚   â”‚   â”‚   â””â”€â”€ debate.ts          # í† ë¡  ë¼ìš´ë“œ ê´€ë¦¬
â”‚   â”‚   â”œâ”€â”€ experts/               # â­ ì „ë¬¸ê°€ ì—°ê²° ì‹œìŠ¤í…œ
â”‚   â”‚   â”‚   â”œâ”€â”€ notification.ts    # ì „ë¬¸ê°€ì—ê²Œ ìƒë‹´ ìš”ì²­ ì•Œë¦¼ (ì´ë©”ì¼)
â”‚   â”‚   â”‚   â””â”€â”€ matching.ts        # ë¶„ì„ ê²°ê³¼ ê¸°ë°˜ ì „ë¬¸ê°€ ì¶”ì²œ
â”‚   â”‚   â”œâ”€â”€ data/
â”‚   â”‚   â”‚   â”œâ”€â”€ enrichment.ts      # ê¸°ì—… ë°ì´í„° ë³´ê°•
â”‚   â”‚   â”‚   â””â”€â”€ fetchers.ts        # ì™¸ë¶€ API í˜¸ì¶œ
â”‚   â”‚   â””â”€â”€ utils/
â”‚   â”‚       â”œâ”€â”€ claude.ts          # Claude API í˜¸ì¶œ
â”‚   â”‚       â””â”€â”€ email.ts           # ì´ë©”ì¼ ë°œì†¡ (SendGrid/Resend)
â”‚   â”œâ”€â”€ package.json
â”‚   â””â”€â”€ tsconfig.json
â”‚
â”œâ”€â”€ firestore.rules                # Firestore ë³´ì•ˆ ê·œì¹™
â”œâ”€â”€ firestore.indexes.json         # Firestore ì¸ë±ìŠ¤
â”œâ”€â”€ firebase.json                  # Firebase ì„¤ì •
â”œâ”€â”€ .firebaserc
â”œâ”€â”€ next.config.js
â”œâ”€â”€ tailwind.config.ts
â”œâ”€â”€ tsconfig.json
â”œâ”€â”€ package.json
â”œâ”€â”€ .env.local                     # í™˜ê²½ë³€ìˆ˜ (ë¡œì»¬)
â””â”€â”€ .env.example
```

---

## 4. Firestore ë°ì´í„° ëª¨ë¸

### 4.1 ì»¬ë ‰ì…˜ êµ¬ì¡°

```typescript
// ============================================
// users/{userId}
// ============================================
interface UserDoc {
  uid: string;
  email: string;
  displayName: string;
  photoURL: string;
  analysisCount: number;        // ì´ ë¶„ì„ íšŸìˆ˜
  dailyUsage: number;           // ì˜¤ëŠ˜ ì‚¬ìš©ëŸ‰ (ë‚¨ìš© ë°©ì§€)
  consultRequestCount: number;  // ì „ë¬¸ê°€ ìƒë‹´ ìš”ì²­ íšŸìˆ˜
  createdAt: Timestamp;
  lastActiveAt: Timestamp;
}

// ============================================
// analyses/{sessionId}  â­ í•µì‹¬ ì»¬ë ‰ì…˜
// ============================================
interface AnalysisDoc {
  id: string;
  userId: string;
  
  // ë¶„ì„ ëŒ€ìƒ
  company: {
    name: string;               // "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤" or "Moderna"
    ticker?: string;            // "KRX:207940" or "MRNA"
    sector: string;             // "ë°”ì´ì˜¤ì‹œë°€ëŸ¬", "mRNA ì¹˜ë£Œì œ" ë“±
    description?: string;       // ê°„ë‹¨ ì„¤ëª…
  };
  
  // ìƒíƒœ ê´€ë¦¬
  status: 'enriching'           // ë°ì´í„° ìˆ˜ì§‘ ì¤‘
    | 'analyzing'               // ì—ì´ì „íŠ¸ ë…ë¦½ ë¶„ì„ ì¤‘
    | 'debating'                // í† ë¡  ì§„í–‰ ì¤‘
    | 'synthesizing'            // ì¢…í•© ë¦¬í¬íŠ¸ ìƒì„± ì¤‘
    | 'completed'               // ì™„ë£Œ
    | 'failed';                 // ì‹¤íŒ¨
  
  currentPhase: string;         // í˜„ì¬ ì§„í–‰ ë‹¨ê³„ í‘œì‹œ
  progress: number;             // 0-100 ì§„í–‰ë¥ 
  
  // ìˆ˜ì§‘ëœ ë°ì´í„° (ì—ì´ì „íŠ¸ì—ê²Œ ì œê³µ)
  enrichedData: {
    clinicalTrials: ClinicalTrialSummary[];
    recentPapers: PaperSummary[];
    financials?: FinancialSummary;
    competitors: CompetitorInfo[];
    regulatoryHistory: RegulatoryEvent[];
  };
  
  // ìµœì¢… ë¦¬í¬íŠ¸
  report?: FinalReport;
  
  // ë©”íƒ€
  createdAt: Timestamp;
  completedAt?: Timestamp;
  totalTokensUsed: number;
  estimatedCost: number;        // USD
}

// ============================================
// analyses/{sessionId}/messages/{messageId}
// ì‹¤ì‹œê°„ í† ë¡  ë©”ì‹œì§€ (ì„œë¸Œì»¬ë ‰ì…˜)
// ============================================
interface MessageDoc {
  id: string;
  sessionId: string;
  
  // ë°œì–¸ì
  agentId: AgentId;             // 'oncologist' | 'pharmacist' | ...
  agentName: string;            // "ê¹€ì„œì—° (ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜)"
  agentRole: string;
  
  // ë°œì–¸ ë‚´ìš©
  phase: 'independent_analysis' // 1ë‹¨ê³„: ë…ë¦½ ë¶„ì„
    | 'cross_examination'       // 2ë‹¨ê³„: êµì°¨ ê²€ì¦
    | 'rebuttal'                // 3ë‹¨ê³„: ë°˜ë°•
    | 'final_verdict';          // 4ë‹¨ê³„: ìµœì¢… ì˜ê²¬
  
  content: string;              // ë§ˆí¬ë‹¤ìš´ í˜•ì‹ì˜ ë°œì–¸ ë‚´ìš©
  
  // êµ¬ì¡°í™”ëœ í‰ê°€ (ë…ë¦½ ë¶„ì„ ì‹œ)
  structuredEval?: {
    scores: Record<string, number>;   // í•­ëª©ë³„ ì ìˆ˜
    keyFindings: string[];
    risks: string[];
    opportunities: string[];
  };
  
  // ë°˜ë°•/êµì°¨ê²€ì¦ ì‹œ
  referencedMessageId?: string;  // ì–´ë–¤ ë°œì–¸ì— ëŒ€í•œ ë°˜ë°•ì¸ì§€
  agreementLevel?: 'agree' | 'partially_agree' | 'disagree' | 'strongly_disagree';
  
  // ë©”íƒ€
  order: number;                // ë°œì–¸ ìˆœì„œ
  createdAt: Timestamp;
  tokenCount: number;
}

// ============================================
// analyses/{sessionId}/conflicts/{conflictId}
// ê°ì§€ëœ ì˜ê²¬ ì¶©ëŒ (ì„œë¸Œì»¬ë ‰ì…˜)
// ============================================
interface ConflictDoc {
  id: string;
  topic: string;                // ì¶©ëŒ ì£¼ì œ
  description: string;
  agentPositions: {
    agentId: AgentId;
    position: string;
    confidence: number;         // 0-1
  }[];
  resolution?: string;          // í•´ì†Œ ì—¬ë¶€ ë° ë°©ë²•
  severity: 'minor' | 'moderate' | 'major';
}

// ============================================
// experts/{expertId}  â­ ì‹¤ì œ ì „ë¬¸ê°€ í”„ë¡œí•„
// ============================================
interface ExpertDoc {
  id: string;
  
  // ê¸°ë³¸ ì •ë³´
  name: string;                   // "í™ê¸¸ë™"
  nameEn: string;                 // "Dr. Hong"
  email: string;                  // ì•Œë¦¼ ìˆ˜ì‹ ìš© (ë¹„ê³µê°œ)
  photoURL?: string;
  
  // ì „ë¬¸ ë¶„ì•¼
  specialty: ExpertSpecialty;     // 'oncology' | 'cardiology' | 'pharmacology' | ...
  specialtyLabel: string;        // "ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜"
  subSpecialties: string[];      // ["íì•”", "ë©´ì—­í•­ì•”ì œ", "ADC"]
  
  // ê²½ë ¥
  credentials: {
    title: string;               // "ì„œìš¸ëŒ€ ì˜ëŒ€ êµìˆ˜"
    hospital?: string;           // "ì„œìš¸ëŒ€í•™êµë³‘ì›"
    experience: string;          // "ì„ìƒì‹œí—˜ 15ë…„"
    education: string[];         // ["ì„œìš¸ëŒ€ ì˜ëŒ€", "Harvard MGH í ë¡œìš°"]
    certifications: string[];    // ["ëŒ€í•œì¢…ì–‘ë‚´ê³¼í•™íšŒ ì „ë¬¸ì˜"]
  };
  
  // ìë¬¸ ê°€ëŠ¥ ì˜ì—­
  consultAreas: string[];        // ["ì„ìƒì‹œí—˜ ë””ìì¸ ìë¬¸", "íŒŒì´í”„ë¼ì¸ í‰ê°€", "ì ì‘ì¦ ì „ëµ"]
  
  // ìë¬¸ë£Œ & ë°©ì‹
  pricing: {
    initialConsult: number;      // ì´ˆê¸° ìƒë‹´ (ì›) - e.g. 300000
    hourlyRate: number;          // ì‹œê°„ë‹¹ (ì›) - e.g. 500000
    currency: 'KRW' | 'USD';
    note?: string;               // "30ë¶„ ë¬´ë£Œ ì‚¬ì „ í†µí™” ê°€ëŠ¥"
  };
  
  consultMethods: ('video' | 'phone' | 'email' | 'in_person')[];
  
  // í”„ë¡œí•„ ìƒíƒœ
  isActive: boolean;             // í˜„ì¬ ìƒë‹´ ê°€ëŠ¥ ì—¬ë¶€
  responseTime: string;          // "ë³´í†µ 24ì‹œê°„ ì´ë‚´ ì‘ë‹µ"
  rating?: number;               // í‰ê·  í‰ì  (1-5)
  reviewCount: number;
  
  // ê´€ë ¨ AI ì—ì´ì „íŠ¸ ë§¤í•‘
  linkedAgentId?: AgentId;       // AI ì—ì´ì „íŠ¸ì™€ì˜ ë§¤í•‘ (ìˆìœ¼ë©´)
  
  createdAt: Timestamp;
  updatedAt: Timestamp;
}

type ExpertSpecialty = 
  | 'oncology'          // ì¢…ì–‘ë‚´ê³¼
  | 'cardiology'        // ì‹¬ì¥ë‚´ê³¼
  | 'neurology'         // ì‹ ê²½ê³¼
  | 'immunology'        // ë©´ì—­í•™
  | 'endocrinology'     // ë‚´ë¶„ë¹„ë‚´ê³¼
  | 'pharmacology'      // ì•½í•™/ì•½ë¬¼ê²½ì œí•™
  | 'regulatory'        // ê·œì œ ì „ë¬¸
  | 'biotech_analyst'   // ë°”ì´ì˜¤ ì• ë„ë¦¬ìŠ¤íŠ¸
  | 'patent_law'        // íŠ¹í—ˆ/IP ë²•ë¥ 
  | 'clinical_trials'   // ì„ìƒì‹œí—˜ ì„¤ê³„
  | 'digital_health'    // ë””ì§€í„¸ í—¬ìŠ¤
  | 'medical_device'    // ì˜ë£Œê¸°ê¸°
  | 'other';

// ============================================
// consultRequests/{requestId}  â­ ìƒë‹´ ìš”ì²­
// ============================================
interface ConsultRequestDoc {
  id: string;
  
  // ìš”ì²­ì
  userId: string;
  userName: string;
  userEmail: string;
  userCompany?: string;          // ì†Œì† (ì„ íƒ)
  userPhone?: string;            // ì—°ë½ì²˜ (ì„ íƒ)
  
  // ëŒ€ìƒ ì „ë¬¸ê°€
  expertId: string;
  expertName: string;
  expertSpecialty: string;
  
  // ìš”ì²­ ë‚´ìš©
  subject: string;               // ìƒë‹´ ì£¼ì œ
  message: string;               // ìƒì„¸ ë‚´ìš©
  
  // AI ë¶„ì„ ì—°ë™ (ìˆìœ¼ë©´)
  linkedAnalysisId?: string;     // ì–´ë–¤ AI ë¶„ì„ì—ì„œ ì—°ê²°ëëŠ”ì§€
  linkedCompany?: string;        // ë¶„ì„ ëŒ€ìƒ ê¸°ì—…ëª…
  aiReportSummary?: string;      // AI ë¦¬í¬íŠ¸ ìš”ì•½ (ì „ë¬¸ê°€ì—ê²Œ ë§¥ë½ ì œê³µ)
  
  // í¬ë§ ì‚¬í•­
  preferredMethod: 'video' | 'phone' | 'email' | 'in_person';
  preferredSchedule?: string;    // "í‰ì¼ ì˜¤í›„ í¬ë§"
  urgency: 'normal' | 'urgent';
  
  // ìƒíƒœ
  status: 'pending'              // ìš”ì²­ ì ‘ìˆ˜
    | 'notified'                 // ì „ë¬¸ê°€ì—ê²Œ ì•Œë¦¼ ë°œì†¡ë¨
    | 'accepted'                 // ì „ë¬¸ê°€ ìˆ˜ë½
    | 'scheduled'                // ì¼ì • í™•ì •
    | 'completed'                // ìƒë‹´ ì™„ë£Œ
    | 'declined'                 // ì „ë¬¸ê°€ ê±°ì ˆ
    | 'cancelled';               // ì‚¬ìš©ì ì·¨ì†Œ
  
  // ì „ë¬¸ê°€ ì‘ë‹µ
  expertResponse?: {
    message: string;
    proposedSchedule?: string;
    respondedAt: Timestamp;
  };
  
  // ë©”íƒ€
  createdAt: Timestamp;
  updatedAt: Timestamp;
  notifiedAt?: Timestamp;
}
```

### 4.2 ìµœì¢… ë¦¬í¬íŠ¸ êµ¬ì¡°

```typescript
interface FinalReport {
  // ì¢…í•© ìš”ì•½
  executiveSummary: string;
  
  // ì¢…í•© ì ìˆ˜ (100ì  ë§Œì )
  overallScore: number;
  
  // ì¶•ë³„ ì ìˆ˜
  dimensionScores: {
    clinicalValue: number;      // ì„ìƒì  ê°€ì¹˜ (0-100)
    regulatoryPath: number;     // ê·œì œ ìŠ¹ì¸ ê°€ëŠ¥ì„± (0-100)
    commercialPotential: number;// ìƒì—…ì  ì ì¬ë ¥ (0-100)
    competitivePosition: number;// ê²½ìŸ ìš°ìœ„ (0-100)
    financialHealth: number;    // ì¬ë¬´ ê±´ì „ì„± (0-100)
    ipStrength: number;         // IP/íŠ¹í—ˆ ê°•ë„ (0-100)
  };
  
  // íŒŒì´í”„ë¼ì¸ ë¶„ì„
  pipelineAnalysis: {
    asset: string;
    indication: string;
    phase: string;
    probabilityOfSuccess: number;
    estimatedPeakSales?: string;
    keyRisks: string[];
    competitorCount: number;
  }[];
  
  // ë¦¬ìŠ¤í¬ ë§¤íŠ¸ë¦­ìŠ¤
  riskMatrix: {
    category: string;
    level: 'low' | 'medium' | 'high' | 'critical';
    description: string;
    mitigants: string[];
  }[];
  
  // ê²½ìŸ êµ¬ë„
  competitorLandscape: {
    company: string;
    overlap: string;            // ê²¹ì¹˜ëŠ” ì˜ì—­
    threat: 'low' | 'medium' | 'high';
    differentiation: string;
  }[];
  
  // ì—ì´ì „íŠ¸ë³„ ìµœì¢… ì˜ê²¬
  agentVerdicts: {
    agentId: AgentId;
    agentName: string;
    verdict: 'strong_positive' | 'positive' | 'neutral' | 'negative' | 'strong_negative';
    summary: string;
    keyArgument: string;
    confidenceLevel: number;    // 0-1
  }[];
  
  // í•©ì˜ vs ë¹„í•©ì˜
  consensusPoints: string[];     // ëª¨ë‘ ë™ì˜í•œ ì 
  dissensusPoints: {             // ì˜ê²¬ì´ ê°ˆë¦° ì 
    topic: string;
    positions: { agentId: AgentId; view: string }[];
  }[];
  
  // í•µì‹¬ ì§ˆë¬¸ (ì¶”ê°€ ë¦¬ì„œì¹˜ í•„ìš”)
  openQuestions: string[];
  
  // â­ ì „ë¬¸ê°€ ìƒë‹´ ì¶”ì²œ
  recommendedExperts: {
    expertId: string;
    expertName: string;
    specialty: string;
    reason: string;              // "ì„ìƒì‹œí—˜ ë””ìì¸ì— ëŒ€í•œ ì‹¬ì¸µ ìë¬¸ í•„ìš”"
    relevantTopics: string[];    // ì´ ë¶„ì„ì—ì„œ í•´ë‹¹ ì „ë¬¸ê°€ê°€ ë„ìš¸ ìˆ˜ ìˆëŠ” í† í”½
  }[];
}
```

---

## 5. ì—ì´ì „íŠ¸ ì‹œìŠ¤í…œ ì„¤ê³„ â­

### 5.1 ì—ì´ì „íŠ¸ ì •ì˜

```typescript
// src/lib/agents/types.ts

type AgentId = 
  | 'oncologist'      // ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜
  | 'pharmacist'      // ì•½ì‚¬/ì•½ë¬¼ê²½ì œí•™ì  
  | 'analyst'         // ë°”ì´ì˜¤ ì• ë„ë¦¬ìŠ¤íŠ¸
  | 'regulatory'      // ê·œì œ ì „ë¬¸ê°€
  | 'immunologist';   // ë©´ì—­í•™/ë‚´ê³¼ ì „ë¬¸ì˜

interface AgentProfile {
  id: AgentId;
  name: string;           // ìºë¦­í„° ì´ë¦„
  nameEn: string;
  title: string;          // ì§í•¨
  avatar: string;         // ì•„ë°”íƒ€ ì´ë¯¸ì§€ ê²½ë¡œ
  color: string;          // í…Œë§ˆ ì»¬ëŸ¬ (UIìš©)
  
  // ì¸ì§€ í”„ë ˆì„ì›Œí¬ â­
  evaluationAxes: string[];     // ì´ ì—ì´ì „íŠ¸ê°€ ì¤‘ì ì ìœ¼ë¡œ ë³´ëŠ” ì¶•
  dataFocus: string[];          // ì£¼ë¡œ ì°¸ì¡°í•˜ëŠ” ë°ì´í„° ìœ í˜•
  biasProfile: string;          // ì„±í–¥ (ë³´ìˆ˜ì /ê³µê²©ì /ê· í˜•ì )
  conflictTriggers: string[];   // ë‹¤ë¥¸ ì—ì´ì „íŠ¸ì™€ ì¶©ëŒí•˜ê¸° ì‰¬ìš´ ì£¼ì œ
}

// ì—ì´ì „íŠ¸ ë ˆì§€ìŠ¤íŠ¸ë¦¬
const AGENTS: Record<AgentId, AgentProfile> = {
  oncologist: {
    id: 'oncologist',
    name: 'ê¹€ì„œì—°',
    nameEn: 'Dr. Kim',
    title: 'ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜ Â· å‰ NCC ì„ìƒì‹œí—˜ì„¼í„°',
    avatar: '/agents/oncologist.png',
    color: '#E74C3C',
    evaluationAxes: [
      'ì„ìƒ endpointì˜ ì‹¤ì§ˆì  ì˜ë¯¸ (OS/PFS/ORR/DOR)',
      'ë¶€ì‘ìš© í”„ë¡œíŒŒì¼ê³¼ ì„ìƒ ê´€ë¦¬ ê°€ëŠ¥ì„±',
      'ê¸°ì¡´ í‘œì¤€ì¹˜ë£Œ ëŒ€ë¹„ ì‹¤ì œ ì²˜ë°© ì „í™˜ ê°€ëŠ¥ì„±',
      'Unmet medical need ì¶©ì¡± ì •ë„',
      'ë°”ì´ì˜¤ë§ˆì»¤ ì „ëµì˜ í•©ë¦¬ì„±',
    ],
    dataFocus: ['ì„ìƒì‹œí—˜ ê²°ê³¼', 'NCCN ê°€ì´ë“œë¼ì¸', 'í•™ìˆ  ë…¼ë¬¸', 'KOL ì˜ê²¬'],
    biasProfile: 'ì„ìƒì  ì˜ë¯¸ì— ë³´ìˆ˜ì . í†µê³„ì ìœ¼ë¡œ ìœ ì˜í•´ë„ ì„ìƒì ìœ¼ë¡œ ì˜ë¯¸ì—†ìœ¼ë©´ ë¶€ì •ì ',
    conflictTriggers: ['ê³¼ëŒ€ ì¶”ì •ëœ ì„ìƒ íš¨ê³¼', 'ì•ˆì „ì„± ê°„ê³¼', 'surrogate endpoint ê³¼ì‹ '],
  },
  
  pharmacist: {
    id: 'pharmacist',
    name: 'ë°•ì¤€í˜¸',
    nameEn: 'Dr. Park',
    title: 'ì•½ë¬¼ê²½ì œí•™ ë°•ì‚¬ Â· ì•½ê°€ í˜‘ìƒ ìë¬¸',
    avatar: '/agents/pharmacist.png',
    color: '#2ECC71',
    evaluationAxes: [
      'ì¦ë¶„ë¹„ìš©íš¨ê³¼ë¹„ (ICER) ë¶„ì„',
      'QALY ì¶”ì •ê³¼ ì§€ë¶ˆìš©ì˜ ì„ê³„ê°’',
      'ë³´í—˜ ê¸‰ì—¬ ë“±ì¬ ê°€ëŠ¥ì„± (í•œêµ­/ë¯¸êµ­)',
      'ì•½ê°€ ê²°ì • ë° í˜‘ìƒ ë ˆë²„ë¦¬ì§€',
      'ì œë„¤ë¦­/ë°”ì´ì˜¤ì‹œë°€ëŸ¬ ì§„ì… ë¦¬ìŠ¤í¬',
    ],
    dataFocus: ['ì•½ê°€ ë°ì´í„°', 'HTA í‰ê°€', 'ê±´ë³´ ê¸‰ì—¬ ì´ë ¥', 'ì•½ë¬¼ê²½ì œì„± ë¶„ì„'],
    biasProfile: 'ë¹„ìš© íš¨ê³¼ì— ì—„ê²©. ì„ìƒì ìœ¼ë¡œ ì¢‹ì•„ë„ ICERê°€ ë†’ìœ¼ë©´ ìƒì—…ì„±ì— íšŒì˜ì ',
    conflictTriggers: ['ë¹„í˜„ì‹¤ì  ì•½ê°€ ê°€ì •', 'ê¸‰ì—¬ ê°€ëŠ¥ì„± ê³¼ëŒ€í‰ê°€', 'ê²½ìŸì•½ ëŒ€ë¹„ ê°€ê²©ê²½ìŸë ¥'],
  },
  
  analyst: {
    id: 'analyst',
    name: 'ì´í˜„ìš°',
    nameEn: 'Daniel Lee',
    title: 'ë°”ì´ì˜¤ ì„¹í„° ìˆ˜ì„ ì• ë„ë¦¬ìŠ¤íŠ¸ Â· CFA',
    avatar: '/agents/analyst.png',
    color: '#3498DB',
    evaluationAxes: [
      'TAM/SAM/SOM ì‹œì¥ ê·œëª¨ ì‚°ì •',
      'Peak sales ì¶”ì • ë° rNPV ëª¨ë¸ë§',
      'ê²½ì˜ì§„ ì—­ëŸ‰ ë° ì‹¤í–‰ë ¥',
      'M&A/ë¼ì´ì„¼ì‹± ë”œ ê°€ëŠ¥ì„±',
      'ìê¸ˆ ì†Œì§„ìœ¨(burn rate) ë° runway',
    ],
    dataFocus: ['ì¬ë¬´ì œí‘œ', 'ì‹œì¥ ë°ì´í„°', 'ë”œ íˆìŠ¤í† ë¦¬', 'ì»¨ì„¼ì„œìŠ¤ ì¶”ì •ì¹˜'],
    biasProfile: 'ì‹œì¥ ê¸°íšŒì— ê³µê²©ì . ì„ìƒ ë¦¬ìŠ¤í¬ë³´ë‹¤ ìƒì—…ì  ì—…ì‚¬ì´ë“œì— ê°€ì¤‘ì¹˜',
    conflictTriggers: ['ì‹œì¥ ê·œëª¨ ê³¼ì†Œí‰ê°€', 'ê²½ìŸ ê³¼ì†Œí‰ê°€', 'ë°¸ë¥˜ì—ì´ì…˜ ê´´ë¦¬'],
  },
  
  regulatory: {
    id: 'regulatory',
    name: 'ì •ë¯¸ë˜',
    nameEn: 'Dr. Jung',
    title: 'å‰ ì‹ì•½ì²˜ ì‹¬ì‚¬ê´€ Â· ê·œì œ ì»¨ì„¤í„´íŠ¸',
    avatar: '/agents/regulatory.png',
    color: '#F39C12',
    evaluationAxes: [
      'ìŠ¹ì¸ í™•ë¥  ë° ì˜ˆìƒ ì‹¬ì‚¬ ê²½ë¡œ',
      'ì„ìƒ ì„¤ê³„ì˜ ê·œì œì  ì í•©ì„±',
      'CMC/ì œì¡° ê´€ë ¨ ë¦¬ìŠ¤í¬',
      'ê¸€ë¡œë²Œ ê·œì œ ì „ëµ (FDA/EMA/MFDS)',
      'Post-marketing ì˜ë¬´ì‚¬í•­ ë° ë¦¬ìŠ¤í¬',
    ],
    dataFocus: ['FDA ì‹¬ì‚¬ ì´ë ¥', 'ìœ ì‚¬ì•½ë¬¼ ìŠ¹ì¸ ì‚¬ë¡€', 'Advisory Committee ê¸°ë¡'],
    biasProfile: 'ê·œì œ ë¦¬ìŠ¤í¬ì— ë§¤ìš° ë³´ìˆ˜ì . ì‘ì€ ê·œì œ ì´ìŠˆë„ í¬ê²Œ í‰ê°€',
    conflictTriggers: ['ê·œì œ ë¦¬ìŠ¤í¬ ê²½ì‹œ', 'ë¹„í˜„ì‹¤ì  ìŠ¹ì¸ íƒ€ì„ë¼ì¸', 'GMP ì´ìŠˆ'],
  },
  
  immunologist: {
    id: 'immunologist',
    name: 'ìµœì€ì§€',
    nameEn: 'Dr. Choi',
    title: 'ë©´ì—­í•™ êµìˆ˜ Â· ê¸°ì´ˆ-ì¤‘ê°œì—°êµ¬ ì „ë¬¸',
    avatar: '/agents/immunologist.png',
    color: '#9B59B6',
    evaluationAxes: [
      'ì‘ìš©ê¸°ì „(MOA)ì˜ ê³¼í•™ì  íƒ€ë‹¹ì„±',
      'íƒ€ê²Ÿ ê²€ì¦ ìˆ˜ì¤€ (target validation)',
      'ë‚´ì„± ê¸°ì „ ë° ê·¹ë³µ ì „ëµ',
      'ë³‘ìš©ìš”ë²• ì‹œë„ˆì§€ ê°€ëŠ¥ì„±',
      'í”Œë«í¼ ê¸°ìˆ ì˜ í™•ì¥ì„±',
    ],
    dataFocus: ['ê¸°ì´ˆì—°êµ¬ ë…¼ë¬¸', 'Nature/Science/Cell ê¸‰ ì¶œíŒë¬¼', 'ì „ì„ìƒ ë°ì´í„°'],
    biasProfile: 'ê³¼í•™ì  ê·¼ê±°ì— ì—„ê²©. ê¸°ì „ì´ ë¶ˆëª…í™•í•˜ë©´ ì„ìƒ ê²°ê³¼ê°€ ì¢‹ì•„ë„ íšŒì˜ì ',
    conflictTriggers: ['ê³¼í•™ì  ê·¼ê±° ë¶€ì¡±', 'MOA ë¶ˆëª…í™•', 'ê³¼ì¥ëœ í”Œë«í¼ ì£¼ì¥'],
  },
};
```

### 5.2 í† ë¡  ì˜¤ì¼€ìŠ¤íŠ¸ë ˆì´ì…˜ í”Œë¡œìš°

```typescript
// functions/src/orchestrate.ts

/**
 * ì „ì²´ í† ë¡  í”Œë¡œìš° (Cloud Functions 2nd Gen)
 * ì˜ˆìƒ ì‹¤í–‰ì‹œê°„: 2-5ë¶„
 * 
 * Phase 1: Data Enrichment (15-30ì´ˆ)
 *   â†’ ì™¸ë¶€ APIì—ì„œ ê¸°ì—… ë°ì´í„° ìˆ˜ì§‘
 * 
 * Phase 2: Independent Analysis (30-60ì´ˆ)
 *   â†’ 5ëª… ì—ì´ì „íŠ¸ê°€ ë³‘ë ¬ë¡œ ë…ë¦½ ë¶„ì„ (Promise.all)
 *   â†’ ê°ìì˜ í‰ê°€ì¶•ì— ë”°ë¼ êµ¬ì¡°í™”ëœ ë¶„ì„ ìƒì„±
 *   â†’ ì¦‰ì‹œ Firestoreì— write â†’ í”„ë¡ íŠ¸ì—ì„œ ì‹¤ì‹œê°„ í‘œì‹œ
 * 
 * Phase 3: Conflict Detection (5ì´ˆ)
 *   â†’ 5ê°œ ë…ë¦½ ë¶„ì„ì—ì„œ ì˜ê²¬ ì¶©ëŒ ìë™ ê°ì§€
 *   â†’ ì¶©ëŒ í† í”½ ì¶”ì¶œ (ì˜ˆ: "ì„ìƒ íš¨ê³¼ í•´ì„", "ì‹œì¥ ê·œëª¨ ì¶”ì •")
 * 
 * Phase 4: Cross-Examination & Rebuttal (30-60ì´ˆ)
 *   â†’ ì¶©ëŒ í† í”½ë³„ë¡œ ê´€ë ¨ ì—ì´ì „íŠ¸ 2-3ëª…ì´ êµì°¨ ê²€ì¦
 *   â†’ ìƒëŒ€ ë¶„ì„ì„ ì½ê³  targeted rebuttal ìƒì„±
 *   â†’ ê° ë°œì–¸ì„ Firestoreì— ìˆœì°¨ write
 * 
 * Phase 5: Final Verdict (15-30ì´ˆ)
 *   â†’ ê° ì—ì´ì „íŠ¸ê°€ í† ë¡  ê²°ê³¼ë¥¼ ë°˜ì˜í•œ ìµœì¢… ì˜ê²¬ ì œì¶œ
 *   â†’ ì ìˆ˜ + í•œì¤„ ì˜ê²¬ + í•µì‹¬ ë…¼ê±°
 * 
 * Phase 6: Synthesis (10-15ì´ˆ)
 *   â†’ ë³„ë„ Claude í˜¸ì¶œë¡œ ì¢…í•© ë¦¬í¬íŠ¸ ìƒì„±
 *   â†’ í•©ì˜ì , ë¹„í•©ì˜ì , ë¦¬ìŠ¤í¬ ë§¤íŠ¸ë¦­ìŠ¤, ì¢…í•© ì ìˆ˜
 */

async function orchestrateAnalysis(sessionId: string, company: CompanyInput) {
  const db = getFirestore();
  const sessionRef = db.doc(`analyses/${sessionId}`);

  try {
    // â”€â”€â”€ Phase 1: Data Enrichment â”€â”€â”€
    await sessionRef.update({ status: 'enriching', currentPhase: 'ê¸°ì—… ë°ì´í„° ìˆ˜ì§‘ ì¤‘...' });
    const enrichedData = await enrichCompanyData(company);
    await sessionRef.update({ enrichedData, progress: 15 });

    // â”€â”€â”€ Phase 2: Independent Analysis (ë³‘ë ¬) â”€â”€â”€
    await sessionRef.update({ status: 'analyzing', currentPhase: 'ì „ë¬¸ê°€ ë…ë¦½ ë¶„ì„ ì¤‘...' });
    
    const independentAnalyses = await Promise.all(
      AGENT_IDS.map(async (agentId, index) => {
        const analysis = await runAgentAnalysis(agentId, company, enrichedData);
        
        // ê° ì—ì´ì „íŠ¸ ë¶„ì„ ì™„ë£Œ ì¦‰ì‹œ Firestoreì— write (ì‹¤ì‹œê°„ í‘œì‹œ)
        await db.collection(`analyses/${sessionId}/messages`).add({
          agentId,
          agentName: AGENTS[agentId].name,
          agentRole: AGENTS[agentId].title,
          phase: 'independent_analysis',
          content: analysis.narrative,
          structuredEval: analysis.structured,
          order: index,
          createdAt: FieldValue.serverTimestamp(),
          tokenCount: analysis.tokenCount,
        });
        
        await sessionRef.update({ progress: 15 + (index + 1) * 10 });
        return { agentId, analysis };
      })
    );

    // â”€â”€â”€ Phase 3: Conflict Detection â”€â”€â”€
    await sessionRef.update({ 
      status: 'debating', 
      currentPhase: 'ì˜ê²¬ ì¶©ëŒ ë¶„ì„ ì¤‘...',
      progress: 70 
    });
    
    const conflicts = await detectConflicts(independentAnalyses);
    
    // ì¶©ëŒ ì •ë³´ ì €ì¥
    for (const conflict of conflicts) {
      await db.collection(`analyses/${sessionId}/conflicts`).add(conflict);
    }

    // â”€â”€â”€ Phase 4: Cross-Examination & Rebuttal â”€â”€â”€
    await sessionRef.update({ currentPhase: 'êµì°¨ ê²€ì¦ ë° í† ë¡  ì¤‘...' });
    
    let messageOrder = AGENT_IDS.length;
    
    for (const conflict of conflicts) {
      const involvedAgents = conflict.agentPositions.map(p => p.agentId);
      
      for (const agentId of involvedAgents) {
        const otherPositions = conflict.agentPositions
          .filter(p => p.agentId !== agentId);
        
        const rebuttal = await generateRebuttal(
          agentId, conflict.topic, otherPositions, enrichedData
        );
        
        await db.collection(`analyses/${sessionId}/messages`).add({
          agentId,
          agentName: AGENTS[agentId].name,
          agentRole: AGENTS[agentId].title,
          phase: 'rebuttal',
          content: rebuttal.content,
          agreementLevel: rebuttal.agreementLevel,
          order: messageOrder++,
          createdAt: FieldValue.serverTimestamp(),
          tokenCount: rebuttal.tokenCount,
        });
        
        // ë°œì–¸ ê°„ ì•½ê°„ì˜ ë”œë ˆì´ (ìì—°ìŠ¤ëŸ¬ìš´ í† ë¡  ëŠë‚Œ)
        await delay(500);
      }
    }

    await sessionRef.update({ progress: 85 });

    // â”€â”€â”€ Phase 5: Final Verdicts â”€â”€â”€
    await sessionRef.update({ currentPhase: 'ìµœì¢… ì˜ê²¬ ìˆ˜ë ´ ì¤‘...' });
    
    const verdicts = await Promise.all(
      AGENT_IDS.map(async (agentId) => {
        const verdict = await generateFinalVerdict(agentId, sessionId);
        
        await db.collection(`analyses/${sessionId}/messages`).add({
          agentId,
          phase: 'final_verdict',
          content: verdict.content,
          structuredEval: verdict.structured,
          order: messageOrder++,
          createdAt: FieldValue.serverTimestamp(),
        });
        
        return { agentId, verdict };
      })
    );

    await sessionRef.update({ progress: 92 });

    // â”€â”€â”€ Phase 6: Synthesis â”€â”€â”€
    await sessionRef.update({ 
      status: 'synthesizing', 
      currentPhase: 'ì¢…í•© ë¦¬í¬íŠ¸ ìƒì„± ì¤‘...' 
    });
    
    const report = await synthesizeReport(
      company, enrichedData, independentAnalyses, conflicts, verdicts
    );

    // â”€â”€â”€ ì™„ë£Œ â”€â”€â”€
    await sessionRef.update({
      status: 'completed',
      currentPhase: 'ë¶„ì„ ì™„ë£Œ',
      progress: 100,
      report,
      completedAt: FieldValue.serverTimestamp(),
    });

  } catch (error) {
    await sessionRef.update({
      status: 'failed',
      currentPhase: `ì˜¤ë¥˜: ${error.message}`,
    });
    throw error;
  }
}
```

### 5.3 ì—ì´ì „íŠ¸ í”„ë¡¬í”„íŠ¸ êµ¬ì¡° (ì˜ˆì‹œ: ì¢…ì–‘ë‚´ê³¼)

```typescript
// src/lib/agents/prompts/oncologist.ts

export function buildOncologistPrompt(
  company: CompanyInfo,
  enrichedData: EnrichedData,
  phase: AnalysisPhase
): string {
  
  const baseContext = `
ë‹¹ì‹ ì€ ê¹€ì„œì—° ë°•ì‚¬ì…ë‹ˆë‹¤. 
ì„œìš¸ëŒ€ ì˜ëŒ€ ì¡¸ì—…, ë¯¸êµ­ MD Anderson Cancer Centerì—ì„œ 
ì¢…ì–‘ë‚´ê³¼ í ë¡œìš°ì‹­ì„ ë§ˆì¹˜ê³  êµ­ë¦½ì•”ì„¼í„° ì„ìƒì‹œí—˜ì„¼í„°ì—ì„œ 
10ë…„ê°„ Phase I-III ì„ìƒì‹œí—˜ì„ ì´ê´„í–ˆìŠµë‹ˆë‹¤.
í˜„ì¬ëŠ” ë°”ì´ì˜¤ íˆ¬ììë¬¸ì„ ê²¸í•˜ê³  ìˆìŠµë‹ˆë‹¤.

[ì„±ê²©ê³¼ ìŠ¤íƒ€ì¼]
- ë°ì´í„°ì— ê¸°ë°˜í•œ ëƒ‰ì² í•œ íŒë‹¨. ê°ì •ì  ê³¼ëŒ€í‰ê°€ë¥¼ ê²½ê³„
- ì„ìƒì ìœ¼ë¡œ ì˜ë¯¸ìˆëŠ” ì°¨ì´(clinically meaningful difference)ì— ì§‘ì°©
- í†µê³„ì  ìœ ì˜ì„±ê³¼ ì„ìƒì  ìœ ì˜ì„±ì„ ì—„ê²©íˆ êµ¬ë¶„
- "p < 0.05ì´ì§€ë§Œ OS ì°¨ì´ê°€ 2ê°œì›”ì´ë©´ ê·¸ê²Œ í™˜ìì—ê²Œ ë¬´ìŠ¨ ì˜ë¯¸ê°€ ìˆë‚˜?"
- ë¶€ì‘ìš© ê´€ë¦¬ ê°€ëŠ¥ì„±ì„ ì‹¤ë¬´ì  ê´€ì ì—ì„œ í‰ê°€
- í•™íšŒ ë°œí‘œë¥¼ ë§ì´ ë‹¤ë…€ì„œ KOL ë„¤íŠ¸ì›Œí¬ì˜ ë¶„ìœ„ê¸°ë¥¼ ì½ì„ ì¤„ ì•

[ì ˆëŒ€ í•˜ì§€ ì•ŠëŠ” ê²ƒ]
- ì „ì„ìƒ ë°ì´í„°ë§Œìœ¼ë¡œ ì„ìƒ ì„±ê³µì„ ì˜ˆë‹¨í•˜ì§€ ì•ŠìŒ
- Surrogate endpoint(ëŒ€ë¦¬ ì§€í‘œ)ë¥¼ ìµœì¢… ê²°ê³¼ì²˜ëŸ¼ í•´ì„í•˜ì§€ ì•ŠìŒ
- ë‹¨ì¼ ì„ìƒì‹œí—˜ ê²°ê³¼ë¥¼ ê³¼ëŒ€í•´ì„í•˜ì§€ ì•ŠìŒ
`;

  if (phase === 'independent_analysis') {
    return `
${baseContext}

[ë¶„ì„ ëŒ€ìƒ]
íšŒì‚¬: ${company.name} (${company.ticker || 'N/A'})
ë¶„ì•¼: ${company.sector}

[ì œê³µëœ ë°ì´í„°]
${formatClinicalTrials(enrichedData.clinicalTrials)}
${formatPapers(enrichedData.recentPapers)}
${formatCompetitors(enrichedData.competitors)}

[ë¶„ì„ ì§€ì‹œ]
ê¹€ì„œì—° ë°•ì‚¬ë¡œì„œ ì´ íšŒì‚¬ë¥¼ ì„ìƒì  ê´€ì ì—ì„œ ë¶„ì„í•´ì£¼ì„¸ìš”.

ë°˜ë“œì‹œ ë‹¤ìŒ êµ¬ì¡°ë¡œ ë‹µë³€í•˜ì„¸ìš”:

1. í•µì‹¬ ì„ìƒ ìì‚° í‰ê°€
   - ê° íŒŒì´í”„ë¼ì¸ì˜ ì„ìƒì  ì˜ë¯¸ë¥¼ êµ¬ì²´ì ìœ¼ë¡œ
   - ì„ìƒì‹œí—˜ ë””ìì¸ì˜ ì ì ˆì„± (endpoint ì„ íƒ, ëŒ€ì¡°êµ° ë“±)
   - ê¸°ì¡´ SoC ëŒ€ë¹„ ì‹¤ì œ ìš°ìœ„ê°€ ìˆëŠ”ì§€

2. ë¶€ì‘ìš© í”„ë¡œíŒŒì¼ ë¶„ì„
   - ì„ìƒì—ì„œ ê´€ë¦¬ ê°€ëŠ¥í•œ ìˆ˜ì¤€ì¸ì§€
   - ê²½ìŸì•½ ëŒ€ë¹„ ì•ˆì „ì„± í”„ë¡œíŒŒì¼ ë¹„êµ

3. ì²˜ë°© ì „í™˜ ê°€ëŠ¥ì„±
   - ì‹¤ì œ ì„ìƒì˜ë¡œì„œ ì´ ì•½ì„ ì²˜ë°©í•  ê²ƒì¸ì§€
   - ì²˜ë°© ì „í™˜ì˜ í—ˆë“¤ì€ ë¬´ì—‡ì¸ì§€

4. ì •ëŸ‰ í‰ê°€
   - ì„ìƒì  ê°€ì¹˜ (0-100ì )
   - ì„ìƒ ì„±ê³µ í™•ë¥  (Phaseë³„)
   - í•µì‹¬ ë¦¬ìŠ¤í¬ 3ê°€ì§€
   - í•µì‹¬ ê¸°íšŒ 3ê°€ì§€

5. í•œì¤„ ìš”ì•½
   - ì´ íšŒì‚¬ë¥¼ í•œ ë¬¸ì¥ìœ¼ë¡œ í‰ê°€í•œë‹¤ë©´

ì†”ì§í•˜ê³  ë‚ ì¹´ë¡­ê²Œ í‰ê°€í•˜ì„¸ìš”. ì¢‹ì€ ì ë„ ë‚˜ìœ ì ë„ ìˆ¨ê¸°ì§€ ë§ˆì„¸ìš”.
`;
  }
  
  // ... rebuttal, final_verdict ë“± phaseë³„ í”„ë¡¬í”„íŠ¸
}
```

---

## 6. í•µì‹¬ API ì—”ë“œí¬ì¸íŠ¸

### 6.1 Next.js API Routes (Vercel)

```typescript
// src/app/api/analysis/start/route.ts
// ì—­í• : ì¸ì¦ í™•ì¸ â†’ Cloud Function íŠ¸ë¦¬ê±° â†’ sessionId ë°˜í™˜

export async function POST(req: Request) {
  // 1. Firebase Auth í† í° ê²€ì¦
  const token = req.headers.get('Authorization')?.replace('Bearer ', '');
  const decoded = await adminAuth.verifyIdToken(token);
  
  // 2. Rate limiting (ë‚¨ìš© ë°©ì§€ â€” ë¬´ë£Œì§€ë§Œ ê¸°ë³¸ ì œí•œ)
  const user = await getUser(decoded.uid);
  if (user.dailyUsage >= 10) {
    return Response.json({ error: 'ì¼ì¼ ë¶„ì„ í•œë„ ì´ˆê³¼ (10íšŒ/ì¼)' }, { status: 429 });
  }
  
  // 3. ë¶„ì„ ì„¸ì…˜ ìƒì„±
  const { company } = await req.json();
  const sessionId = crypto.randomUUID();
  
  await adminDb.doc(`analyses/${sessionId}`).set({
    id: sessionId,
    userId: decoded.uid,
    company,
    status: 'enriching',
    progress: 0,
    createdAt: FieldValue.serverTimestamp(),
    totalTokensUsed: 0,
    estimatedCost: 0,
  });
  
  // 4. Cloud Function íŠ¸ë¦¬ê±° (ë¹„ë™ê¸°)
  await triggerOrchestration(sessionId, company);
  
  // 5. sessionId ì¦‰ì‹œ ë°˜í™˜ (í”„ë¡ íŠ¸ì—ì„œ Firestore êµ¬ë… ì‹œì‘)
  return Response.json({ sessionId });
}
```

### 6.2 Cloud Functions (Firebase)

```typescript
// functions/src/index.ts

import { onDocumentCreated } from 'firebase-functions/v2/firestore';

// ë¶„ì„ ë¬¸ì„œ ìƒì„± ì‹œ ìë™ íŠ¸ë¦¬ê±°
export const onAnalysisCreated = onDocumentCreated(
  {
    document: 'analyses/{sessionId}',
    timeoutSeconds: 540,     // 9ë¶„ íƒ€ì„ì•„ì›ƒ
    memory: '1GiB',
    region: 'asia-northeast3', // ì„œìš¸ ë¦¬ì „
  },
  async (event) => {
    const data = event.data?.data();
    if (!data) return;
    
    await orchestrateAnalysis(event.params.sessionId, data.company);
  }
);

// â­ ìƒë‹´ ìš”ì²­ ìƒì„± ì‹œ ì „ë¬¸ê°€ì—ê²Œ ì´ë©”ì¼ ì•Œë¦¼
export const onConsultRequestCreated = onDocumentCreated(
  {
    document: 'consultRequests/{requestId}',
    region: 'asia-northeast3',
  },
  async (event) => {
    const request = event.data?.data() as ConsultRequestDoc;
    if (!request) return;
    
    // ì „ë¬¸ê°€ ì •ë³´ ì¡°íšŒ
    const expertSnap = await getFirestore()
      .doc(`experts/${request.expertId}`).get();
    const expert = expertSnap.data() as ExpertDoc;
    
    // ì´ë©”ì¼ ë°œì†¡ (Resend)
    await sendConsultNotification({
      to: expert.email,
      expertName: expert.name,
      userName: request.userName,
      subject: request.subject,
      message: request.message,
      linkedCompany: request.linkedCompany,
      aiReportSummary: request.aiReportSummary,
      preferredMethod: request.preferredMethod,
    });
    
    // ìƒíƒœ ì—…ë°ì´íŠ¸
    await event.data?.ref.update({
      status: 'notified',
      notifiedAt: FieldValue.serverTimestamp(),
    });
  }
);
```

---

## 7. í”„ë¡ íŠ¸ì—”ë“œ í•µì‹¬ ì»´í¬ë„ŒíŠ¸

### 7.1 ì‹¤ì‹œê°„ í† ë¡  ë·° (í•µì‹¬ UX)

```typescript
// src/hooks/useDebateStream.ts

export function useDebateStream(sessionId: string) {
  const [messages, setMessages] = useState<MessageDoc[]>([]);
  const [status, setStatus] = useState<AnalysisStatus>('enriching');
  const [progress, setProgress] = useState(0);
  const [conflicts, setConflicts] = useState<ConflictDoc[]>([]);
  
  useEffect(() => {
    // ì„¸ì…˜ ìƒíƒœ êµ¬ë…
    const unsubSession = onSnapshot(
      doc(db, 'analyses', sessionId),
      (snap) => {
        const data = snap.data();
        setStatus(data.status);
        setProgress(data.progress);
      }
    );
    
    // ë©”ì‹œì§€ ì‹¤ì‹œê°„ êµ¬ë… (ë°œì–¸ ìˆœì„œëŒ€ë¡œ)
    const unsubMessages = onSnapshot(
      query(
        collection(db, `analyses/${sessionId}/messages`),
        orderBy('order', 'asc')
      ),
      (snap) => {
        const msgs = snap.docs.map(d => ({ id: d.id, ...d.data() }));
        setMessages(msgs);
      }
    );
    
    // ì¶©ëŒ êµ¬ë…
    const unsubConflicts = onSnapshot(
      collection(db, `analyses/${sessionId}/conflicts`),
      (snap) => {
        setConflicts(snap.docs.map(d => ({ id: d.id, ...d.data() })));
      }
    );
    
    return () => {
      unsubSession();
      unsubMessages();
      unsubConflicts();
    };
  }, [sessionId]);
  
  return { messages, status, progress, conflicts };
}
```

### 7.2 í™”ë©´ êµ¬ì„± ì™€ì´ì–´í”„ë ˆì„

**í† ë¡  ë·°**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  BioPanel AI      [Dashboard]  [ë‚´ ë¶„ì„]  [ì „ë¬¸ê°€] [Profile] â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚              â”‚                                              â”‚
â”‚  ì—ì´ì „íŠ¸     â”‚  ğŸ“Š ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ë¶„ì„                      â”‚
â”‚  íŒ¨ë„        â”‚  â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” 67%                â”‚
â”‚              â”‚  í˜„ì¬: êµì°¨ ê²€ì¦ ë° í† ë¡  ì¤‘...                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚                                              â”‚
â”‚  â”‚ ğŸ”´     â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ ê¹€ì„œì—°  â”‚  â”‚  â”‚ Phase 1: ë…ë¦½ ë¶„ì„                       â”‚ â”‚
â”‚  â”‚ ì¢…ì–‘ë‚´ê³¼â”‚  â”‚  â”‚                                         â”‚ â”‚
â”‚  â”‚ ë°œì–¸ì¤‘..â”‚  â”‚  â”‚  ğŸ”´ ê¹€ì„œì—° (ì¢…ì–‘ë‚´ê³¼)                     â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”‚  "ë°”ì´ì˜¤ì‹œë°€ëŸ¬ í¬íŠ¸í´ë¦¬ì˜¤ëŠ” ê²€ì¦ëœ ê¸°ìˆ ë ¥  â”‚ â”‚
â”‚              â”‚  â”‚   ê¸°ë°˜ì´ë‚˜, ì‹ ì•½ íŒŒì´í”„ë¼ì¸ì˜ ì„ìƒì         â”‚ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚   ì°¨ë³„í™”ê°€ ë¶€ì¡±í•©ë‹ˆë‹¤. íŠ¹íˆ..."            â”‚ â”‚
â”‚  â”‚ ğŸŸ¢     â”‚  â”‚  â”‚  ğŸ“Š ì„ìƒì  ê°€ì¹˜: 72/100                   â”‚ â”‚
â”‚  â”‚ ë°•ì¤€í˜¸  â”‚  â”‚  â”‚                                         â”‚ â”‚
â”‚  â”‚ ì•½ë¬¼ê²½ì œâ”‚  â”‚  â”‚  ğŸŸ¢ ë°•ì¤€í˜¸ (ì•½ë¬¼ê²½ì œí•™)                    â”‚ â”‚
â”‚  â”‚ ì™„ë£Œ âœ“ â”‚  â”‚  â”‚  "ë°”ì´ì˜¤ì‹œë°€ëŸ¬ì˜ ICERëŠ” ì˜¤ë¦¬ì§€ë„ ëŒ€ë¹„      â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”‚   í™•ì‹¤í•œ ë¹„ìš© ìš°ìœ„ê°€ ìˆìœ¼ë‚˜, ê°êµ­         â”‚ â”‚
â”‚              â”‚  â”‚   ì•½ê°€ ì •ì±…ì— ë”°ë¥¸ ë³€ë™ì„±ì´..."             â”‚ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚  ğŸ“Š ê²½ì œì„±: 81/100                        â”‚ â”‚
â”‚  â”‚ ğŸ”µ     â”‚  â”‚  â”‚                                         â”‚ â”‚
â”‚  â”‚ ì´í˜„ìš°  â”‚  â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚  â”‚ ì• ë„ë¦¬ìŠ¤â”‚  â”‚  â”‚ âš¡ ì˜ê²¬ ì¶©ëŒ ê°ì§€                         â”‚ â”‚
â”‚  â”‚ ì™„ë£Œ âœ“ â”‚  â”‚  â”‚ "ì‹œì¥ ê·œëª¨ ì¶”ì •" â€” ì´í˜„ìš° vs ë°•ì¤€í˜¸       â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚              â”‚  â”‚ Phase 2: êµì°¨ ê²€ì¦                        â”‚ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚                                         â”‚ â”‚
â”‚  â”‚ ğŸŸ¡     â”‚  â”‚  â”‚  ğŸ”µ ì´í˜„ìš° â†’ ğŸŸ¢ ë°•ì¤€í˜¸ì—ê²Œ:               â”‚ â”‚
â”‚  â”‚ ì •ë¯¸ë˜  â”‚  â”‚  â”‚  "ë°•ì¤€í˜¸ ë°•ì‚¬ë‹˜ì˜ ê¸‰ì—¬ ê°€ëŠ¥ì„± ë¶„ì„ì—ëŠ”    â”‚ â”‚
â”‚  â”‚ ê·œì œ    â”‚  â”‚  â”‚   ë™ì˜í•˜ì§€ë§Œ, ë¯¸êµ­ ìë¹„ë¶€ë‹´ ì‹œì¥ì„         â”‚ â”‚
â”‚  â”‚ ëŒ€ê¸°ì¤‘  â”‚  â”‚  â”‚   ê³¼ì†Œí‰ê°€í•˜ì…¨ìŠµë‹ˆë‹¤..."                  â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”‚                                         â”‚ â”‚
â”‚              â”‚  â”‚  ğŸŸ¢ ë°•ì¤€í˜¸ â†’ ğŸ”µ ì´í˜„ìš°ì—ê²Œ:                â”‚ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚  "ì´í˜„ìš° ì• ë„ë¦¬ìŠ¤íŠ¸ì˜ peak sales ì¶”ì •     â”‚ â”‚
â”‚  â”‚ ğŸŸ£     â”‚  â”‚  â”‚   $3.2BëŠ” biosimilar erosionì„            â”‚ â”‚
â”‚  â”‚ ìµœì€ì§€  â”‚  â”‚  â”‚   ì¶©ë¶„íˆ ë°˜ì˜í•˜ì§€ ì•Šì•˜ìŠµë‹ˆë‹¤..."           â”‚ â”‚
â”‚  â”‚ ë©´ì—­í•™  â”‚  â”‚  â”‚                                         â”‚ â”‚
â”‚  â”‚ ëŒ€ê¸°ì¤‘  â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚                                              â”‚
â”‚              â”‚  [ë¦¬í¬íŠ¸ ë³´ê¸°] (ë¶„ì„ ì™„ë£Œ í›„ í™œì„±í™”)            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Powered by BioPanel AI Â· ë¬´ë£Œ ì„œë¹„ìŠ¤                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**ë¦¬í¬íŠ¸ ë·° (í•˜ë‹¨ â€” ì „ë¬¸ê°€ ì—°ê²° CTA)**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                             â”‚
â”‚  â”€â”€â”€ ì¢…í•© ë¦¬í¬íŠ¸ â”€â”€â”€ ì ìˆ˜ â”€â”€â”€ íˆíŠ¸ë§µ â”€â”€â”€ (ìƒëµ) â”€â”€â”€         â”‚
â”‚                                                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚  ğŸ’¡ AI ë¶„ì„ì„ ë„˜ì–´, ì‹¤ì œ ì „ë¬¸ê°€ì˜ ì˜ê²¬ì´ í•„ìš”í•˜ì‹ ê°€ìš”?        â”‚
â”‚                                                             â”‚
â”‚  ì´ ë¶„ì„ê³¼ ê´€ë ¨ëœ ì „ë¬¸ê°€ë¥¼ ì¶”ì²œí•´ë“œë¦½ë‹ˆë‹¤:                     â”‚
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚
â”‚  â”‚ ğŸ‘¨â€âš•ï¸ í•œì •ìˆ˜ êµìˆ˜     â”‚  â”‚ ğŸ‘©â€ğŸ”¬ ìœ¤ì†Œì˜ ë°•ì‚¬     â”‚               â”‚
â”‚  â”‚ ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜    â”‚  â”‚ ë°”ì´ì˜¤ì‹œë°€ëŸ¬ ì „ë¬¸  â”‚               â”‚
â”‚  â”‚ â˜… 4.9 (23ê±´)      â”‚  â”‚ â˜… 4.8 (17ê±´)      â”‚               â”‚
â”‚  â”‚                   â”‚  â”‚                   â”‚               â”‚
â”‚  â”‚ "ì´ ë¶„ì„ì˜ ì„ìƒ    â”‚  â”‚ "ë°”ì´ì˜¤ì‹œë°€ëŸ¬ ì‹œì¥ â”‚               â”‚
â”‚  â”‚  endpoint í•´ì„ì—   â”‚  â”‚  ì§„ì… ì „ëµì— ëŒ€í•´  â”‚               â”‚
â”‚  â”‚  ì‹¬ì¸µ ìë¬¸ ê°€ëŠ¥"   â”‚  â”‚  ìë¬¸ ê°€ëŠ¥"        â”‚               â”‚
â”‚  â”‚                   â”‚  â”‚                   â”‚               â”‚
â”‚  â”‚ ì´ˆê¸°ìƒë‹´ 30ë§Œì›    â”‚  â”‚ ì´ˆê¸°ìƒë‹´ 25ë§Œì›    â”‚               â”‚
â”‚  â”‚ [í”„ë¡œí•„ ë³´ê¸°]      â”‚  â”‚ [í”„ë¡œí•„ ë³´ê¸°]      â”‚               â”‚
â”‚  â”‚ [ğŸ“© ìƒë‹´ ìš”ì²­]     â”‚  â”‚ [ğŸ“© ìƒë‹´ ìš”ì²­]     â”‚               â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚
â”‚                                                             â”‚
â”‚  [ì „ì²´ ì „ë¬¸ê°€ ë³´ê¸° â†’]                                        â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**ì „ë¬¸ê°€ í”„ë¡œí•„ í˜ì´ì§€**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  BioPanel AI      [Dashboard]  [ë‚´ ë¶„ì„]  [ì „ë¬¸ê°€] [Profile] â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”  í•œì •ìˆ˜ êµìˆ˜                                       â”‚
â”‚  â”‚ ì‚¬ì§„  â”‚  ì¢…ì–‘ë‚´ê³¼ ì „ë¬¸ì˜ Â· ì„œìš¸ëŒ€í•™êµë³‘ì›                    â”‚
â”‚  â”‚      â”‚  â˜… 4.9 (23ê±´ ìƒë‹´ ì™„ë£Œ) Â· ë³´í†µ 24ì‹œê°„ ë‚´ ì‘ë‹µ       â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”˜                                                   â”‚
â”‚                                                             â”‚
â”‚  â”€â”€â”€ ì „ë¬¸ ë¶„ì•¼ â”€â”€â”€                                           â”‚
â”‚  [íì•”] [ë©´ì—­í•­ì•”ì œ] [ADC] [ì„ìƒì‹œí—˜ ë””ìì¸]                   â”‚
â”‚                                                             â”‚
â”‚  â”€â”€â”€ ê²½ë ¥ â”€â”€â”€                                                â”‚
â”‚  Â· ì„œìš¸ëŒ€ ì˜ëŒ€ ì¡¸ì—…, MD Anderson í ë¡œìš°                       â”‚
â”‚  Â· êµ­ë¦½ì•”ì„¼í„° ì„ìƒì‹œí—˜ì„¼í„° 10ë…„                               â”‚
â”‚  Â· Phase I-III ì„ìƒì‹œí—˜ 50ê±´+ ì´ê´„                           â”‚
â”‚                                                             â”‚
â”‚  â”€â”€â”€ ìë¬¸ ê°€ëŠ¥ ì˜ì—­ â”€â”€â”€                                      â”‚
â”‚  Â· í•­ì•”ì œ íŒŒì´í”„ë¼ì¸ ì„ìƒì  ê°€ì¹˜ í‰ê°€                         â”‚
â”‚  Â· ì„ìƒì‹œí—˜ ë””ìì¸ ë° endpoint ìë¬¸                          â”‚
â”‚  Â· ì ì‘ì¦ í™•ì¥ ì „ëµ                                          â”‚
â”‚                                                             â”‚
â”‚  â”€â”€â”€ ìƒë‹´ ë°©ì‹ & ë¹„ìš© â”€â”€â”€                                    â”‚
â”‚  Â· ì´ˆê¸° ìƒë‹´ (30ë¶„): 30ë§Œì›                                  â”‚
â”‚  Â· ì‹¬ì¸µ ìë¬¸ (ì‹œê°„ë‹¹): 50ë§Œì›                                â”‚
â”‚  Â· ë°©ì‹: í™”ìƒí†µí™” / ì „í™” / ì´ë©”ì¼                            â”‚
â”‚  Â· ğŸ’¬ "30ë¶„ ë¬´ë£Œ ì‚¬ì „ í†µí™” ê°€ëŠ¥"                             â”‚
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚         [ğŸ“© ìƒë‹´ ìš”ì²­í•˜ê¸°]               â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**ìƒë‹´ ìš”ì²­ í¼**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                             â”‚
â”‚  ğŸ“© í•œì •ìˆ˜ êµìˆ˜ë‹˜ê»˜ ìƒë‹´ ìš”ì²­                                 â”‚
â”‚                                                             â”‚
â”‚  ìƒë‹´ ì£¼ì œ *                                                 â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì‹ ì•½ íŒŒì´í”„ë¼ì¸ ì„ìƒ...   â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                             â”‚
â”‚  ìƒì„¸ ë‚´ìš© *                                                 â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚ AI ë¶„ì„ ê²°ê³¼ ì„ìƒ endpoint í•´ì„ì—        â”‚                â”‚
â”‚  â”‚ ëŒ€í•œ ì „ë¬¸ê°€ ì˜ê²¬ì´ í•„ìš”í•©ë‹ˆë‹¤.            â”‚                â”‚
â”‚  â”‚ íŠ¹íˆ Phase 2 ê²°ê³¼ì˜ OS ì „í™˜ ê°€ëŠ¥ì„±ì—     â”‚                â”‚
â”‚  â”‚ ëŒ€í•´...                                 â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                             â”‚
â”‚  ğŸ“ AI ë¶„ì„ ë¦¬í¬íŠ¸ ì²¨ë¶€                                      â”‚
â”‚  âœ… ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ë¶„ì„ ë¦¬í¬íŠ¸ (2025.02.10)                 â”‚
â”‚     (ì „ë¬¸ê°€ì—ê²Œ AI ë¶„ì„ ë§¥ë½ì´ í•¨ê»˜ ì „ë‹¬ë©ë‹ˆë‹¤)               â”‚
â”‚                                                             â”‚
â”‚  í¬ë§ ìƒë‹´ ë°©ì‹ *                                            â”‚
â”‚  (â—) í™”ìƒí†µí™”  ( ) ì „í™”  ( ) ì´ë©”ì¼                          â”‚
â”‚                                                             â”‚
â”‚  í¬ë§ ì¼ì •                                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚ í‰ì¼ ì˜¤í›„ 2-5ì‹œ í¬ë§                      â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                             â”‚
â”‚  ì—°ë½ì²˜ *                                                    â”‚
â”‚  ì´ë©”ì¼: michael@example.com (ìë™ì…ë ¥)                      â”‚
â”‚  ì „í™”ë²ˆí˜¸: â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” (ì„ íƒ)                   â”‚
â”‚           â”‚                      â”‚                          â”‚
â”‚           â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                          â”‚
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚  â”‚           [ìƒë‹´ ìš”ì²­ ë³´ë‚´ê¸°]              â”‚                â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                             â”‚
â”‚  * ìš”ì²­ ì ‘ìˆ˜ í›„ ì „ë¬¸ê°€ì—ê²Œ ì´ë©”ì¼ë¡œ ì•Œë¦¼ì´ ì „ì†¡ë©ë‹ˆë‹¤.         â”‚
â”‚  * ì „ë¬¸ê°€ê°€ ìˆ˜ë½í•˜ë©´ ì¼ì • ì¡°ìœ¨ ì•ˆë‚´ë¥¼ ë³´ë‚´ë“œë¦½ë‹ˆë‹¤.            â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 8. í™˜ê²½ë³€ìˆ˜

```env
# .env.local

# Firebase
NEXT_PUBLIC_FIREBASE_API_KEY=
NEXT_PUBLIC_FIREBASE_AUTH_DOMAIN=
NEXT_PUBLIC_FIREBASE_PROJECT_ID=
NEXT_PUBLIC_FIREBASE_STORAGE_BUCKET=
NEXT_PUBLIC_FIREBASE_MESSAGING_SENDER_ID=
NEXT_PUBLIC_FIREBASE_APP_ID=

# Firebase Admin (ì„œë²„ ì‚¬ì´ë“œ)
FIREBASE_ADMIN_PROJECT_ID=
FIREBASE_ADMIN_CLIENT_EMAIL=
FIREBASE_ADMIN_PRIVATE_KEY=

# Anthropic
ANTHROPIC_API_KEY=

# ì™¸ë¶€ ë°ì´í„° API
NCBI_API_KEY=              # PubMed E-utilities
SEC_EDGAR_USER_AGENT=      # SEC EDGAR (ì´ë©”ì¼ í˜•ì‹)

# Vercel
VERCEL_URL=

# ì´ë©”ì¼ ì•Œë¦¼ (ì „ë¬¸ê°€ ìƒë‹´ ìš”ì²­ ì•Œë¦¼ìš©)
RESEND_API_KEY=                # Resend (ë˜ëŠ” SENDGRID_API_KEY)
NOTIFICATION_FROM_EMAIL=       # noreply@biopanel.ai
```

---

## 9. ê°œë°œ ë¡œë“œë§µ

### Phase 0: í”„ë¡œì íŠ¸ ì„¸íŒ… (1ì¼)
- [x] Next.js + TypeScript + Tailwind ì´ˆê¸°í™”
- [x] Firebase í”„ë¡œì íŠ¸ ìƒì„± ë° ì—°ë™
- [x] Vercel ë°°í¬ ì„¤ì •
- [x] ESLint, Prettier ì„¤ì •
- [x] í™˜ê²½ë³€ìˆ˜ ì„¸íŒ…

### Phase 1: ì¸ì¦ + ê¸°ë³¸ ë ˆì´ì•„ì›ƒ (2ì¼)
- [ ] Firebase Auth (Google ë¡œê·¸ì¸) êµ¬í˜„
- [ ] ë©”ì¸ ë ˆì´ì•„ì›ƒ (Header, Sidebar)
- [ ] Dashboard í˜ì´ì§€ (ë¹ˆ ìƒíƒœ)
- [ ] ë³´í˜¸ ë¼ìš°íŠ¸ ì„¤ì •

### Phase 2: ë‹¨ì¼ ì—ì´ì „íŠ¸ íŒŒì´í”„ë¼ì¸ (3ì¼)
- [ ] ê¸°ì—…ëª… ì…ë ¥ UI
- [ ] ë°ì´í„° ìˆ˜ì§‘ ëª¨ë“ˆ (ClinicalTrials.gov, PubMed)
- [ ] ì¢…ì–‘ë‚´ê³¼ ì—ì´ì „íŠ¸ 1ëª…ë§Œìœ¼ë¡œ ë¶„ì„ íŒŒì´í”„ë¼ì¸ êµ¬ì¶•
- [ ] Firestoreì— ê²°ê³¼ ì €ì¥ + ì‹¤ì‹œê°„ í‘œì‹œ
- [ ] **ì´ ë‹¨ê³„ì—ì„œ end-to-end ì‘ë™ í™•ì¸**

### Phase 3: ë©€í‹°ì—ì´ì „íŠ¸ + í† ë¡  (4ì¼)
- [ ] ë‚˜ë¨¸ì§€ 4ëª… ì—ì´ì „íŠ¸ í”„ë¡¬í”„íŠ¸ ì‘ì„±
- [ ] ë³‘ë ¬ ë…ë¦½ ë¶„ì„ êµ¬í˜„
- [ ] ì˜ê²¬ ì¶©ëŒ ê°ì§€ ë¡œì§
- [ ] êµì°¨ ê²€ì¦ / ë°˜ë°• ë¼ìš´ë“œ
- [ ] í† ë¡  íƒ€ì„ë¼ì¸ UI

### Phase 4: ë¦¬í¬íŠ¸ ìƒì„± (3ì¼)
- [ ] ì¢…í•© ë¦¬í¬íŠ¸ ìƒì„± ë¡œì§
- [ ] ë¦¬í¬íŠ¸ ë·° UI (ì ìˆ˜, íˆíŠ¸ë§µ, ë§¤íŠ¸ë¦­ìŠ¤)
- [ ] PDF ë‚´ë³´ë‚´ê¸°
- [ ] ë¶„ì„ ì´ë ¥ ëª©ë¡ / ëŒ€ì‹œë³´ë“œ

### Phase 5: ì „ë¬¸ê°€ ì—°ê²° ì‹œìŠ¤í…œ (3ì¼) â­ NEW
- [ ] ì „ë¬¸ê°€ í”„ë¡œí•„ DB êµ¬ì¶• (Firestore experts ì»¬ë ‰ì…˜)
- [ ] ì „ë¬¸ê°€ ëª©ë¡/ê²€ìƒ‰ í˜ì´ì§€ (ë¶„ì•¼ë³„ í•„í„°)
- [ ] ì „ë¬¸ê°€ ìƒì„¸ í”„ë¡œí•„ í˜ì´ì§€
- [ ] ìƒë‹´ ìš”ì²­ í¼ + Firestore ì €ì¥
- [ ] ìƒë‹´ ìš”ì²­ ì‹œ ì „ë¬¸ê°€ì—ê²Œ ì´ë©”ì¼ ì•Œë¦¼ (Resend)
- [ ] AI ë¶„ì„ ë¦¬í¬íŠ¸ì™€ ìƒë‹´ ìš”ì²­ ì—°ë™ (ë§¥ë½ ìë™ ì „ë‹¬)
- [ ] ë¦¬í¬íŠ¸ í•˜ë‹¨ "ì¶”ì²œ ì „ë¬¸ê°€" CTA ì»´í¬ë„ŒíŠ¸

### Phase 6: í´ë¦¬ì‹± + ëŸ°ì¹­ (2ì¼)
- [ ] ì—ëŸ¬ í•¸ë“¤ë§ ê°•í™”
- [ ] ë¡œë”© ìƒíƒœ UX ê°œì„ 
- [ ] ëœë”© í˜ì´ì§€
- [ ] í”„ë¡œë•ì…˜ ë°°í¬

**ì´ ì˜ˆìƒ ê¸°ê°„: ì•½ 18ì¼ (2.5ì£¼ + Î±)**

---

## 10. ë¹„ìš© êµ¬ì¡° & ìˆ˜ìµ ëª¨ë¸

### ìš´ì˜ ë¹„ìš© (ì˜ˆìƒ)

| í•­ëª© | ì›” 100íšŒ ë¶„ì„ ê¸°ì¤€ | ë¹„ê³  |
|------|-------------------|------|
| Claude API | $100-200 | ì„¸ì…˜ë‹¹ ~15 í˜¸ì¶œ, Sonnet 4 ê¸°ì¤€ |
| Firebase Firestore | $5-10 | ì½ê¸°/ì“°ê¸° ê¸°ì¤€ |
| Firebase Functions | $0-5 | ë¬´ë£Œ í‹°ì–´ ì¶©ë¶„ |
| Vercel | $0-20 | Hobby: ë¬´ë£Œ, Pro: $20/ì›” |
| Resend (ì´ë©”ì¼) | $0 | ì›” 3,000ê±´ ë¬´ë£Œ |
| ë„ë©”ì¸ | $12/ë…„ | |
| **ì´ ì›” ë¹„ìš©** | **$110-240** | ì´ˆê¸° MVP ê¸°ì¤€ |

### ì„œë¹„ìŠ¤ ëª¨ë¸: AI ë¶„ì„ ë¬´ë£Œ + ì „ë¬¸ê°€ ì—°ê²° ìˆ˜ìµí™”

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                 â”‚
â”‚   ğŸ†“ ë¬´ë£Œ ë ˆì´ì–´ (AI ë¶„ì„)                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                     â”‚
â”‚   Â· AI ë©€í‹°ì—ì´ì „íŠ¸ ê¸°ì—… ë¶„ì„: ì™„ì „ ë¬´ë£Œ          â”‚
â”‚   Â· ì‹¤ì‹œê°„ í† ë¡  ìŠ¤íŠ¸ë¦¬ë°: ë¬´ë£Œ                    â”‚
â”‚   Â· ì¢…í•© ë¦¬í¬íŠ¸ + PDF ë‚´ë³´ë‚´ê¸°: ë¬´ë£Œ              â”‚
â”‚   Â· ë¶„ì„ ì´ë ¥ ì €ì¥: ë¬´ë£Œ                          â”‚
â”‚                                                 â”‚
â”‚   â†’ ëª©ì : ì‚¬ìš©ì ìœ ì… + ë¶„ì„ í’ˆì§ˆë¡œ ì‹ ë¢° êµ¬ì¶•     â”‚
â”‚                                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                 â”‚
â”‚   ğŸ’° ìˆ˜ìµ ë ˆì´ì–´ (ì „ë¬¸ê°€ ì—°ê²°)                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                     â”‚
â”‚   Â· ì „ë¬¸ê°€ í”„ë¡œí•„ ì—´ëŒ: ë¬´ë£Œ                      â”‚
â”‚   Â· ìƒë‹´ ìš”ì²­ ì ‘ìˆ˜: ë¬´ë£Œ                          â”‚
â”‚   Â· ì‹¤ì œ ìƒë‹´ ì„±ì‚¬ ì‹œ: ì¤‘ê°œ ìˆ˜ìˆ˜ë£Œ               â”‚
â”‚                                                 â”‚
â”‚   ìˆ˜ìˆ˜ë£Œ ëª¨ë¸ (ì˜ˆì‹œ):                             â”‚
â”‚   Â· ìƒë‹´ ì„±ì‚¬ ê±´ë‹¹ ìˆ˜ìˆ˜ë£Œ: ìƒë‹´ë£Œì˜ 15-20%        â”‚
â”‚   Â· ë˜ëŠ” ì „ë¬¸ê°€ ì›”ì •ì•¡ ë¦¬ìŠ¤íŒ…ë¹„: 5-10ë§Œì›/ì›”      â”‚
â”‚   Â· ë˜ëŠ” í•˜ì´ë¸Œë¦¬ë“œ (ë‚®ì€ ë¦¬ìŠ¤íŒ…ë¹„ + ë‚®ì€ ìˆ˜ìˆ˜ë£Œ) â”‚
â”‚                                                 â”‚
â”‚   â†’ ëª©ì : AIê°€ í•´ê²° ëª»í•˜ëŠ” ì˜ì—­ì—ì„œ ìì—°ìŠ¤ëŸ½ê²Œ     â”‚
â”‚     ìˆ˜ìµ ë°œìƒ. ì‚¬ìš©ìì—ê²Œ ê°•ì œí•˜ì§€ ì•ŠìŒ             â”‚
â”‚                                                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### ì™œ ì´ ëª¨ë¸ì´ ì¢‹ì€ê°€

1. **ì§„ì… ì¥ë²½ ì œë¡œ**: AI ë¶„ì„ì´ ë¬´ë£Œì´ë¯€ë¡œ ì‚¬ìš©ìê°€ ë¶€ë‹´ ì—†ì´ ì¨ë´„
2. **ìì—°ìŠ¤ëŸ¬ìš´ ì „í™˜**: AI ë¶„ì„ â†’ "ì´ ë¶€ë¶„ì€ ì „ë¬¸ê°€ í™•ì¸ì´ í•„ìš”" â†’ ì „ë¬¸ê°€ ì—°ê²°
3. **ì–‘ë©´ í”Œë«í¼**: ì‚¬ìš©ìê°€ ë§ì•„ì§€ë©´ ì „ë¬¸ê°€ë„ ìë°œì ìœ¼ë¡œ ë“±ë¡ (ë¦¬ë“œ í™•ë³´ ì±„ë„)
4. **AI ë¶„ì„ì´ ì „ë¬¸ê°€ì˜ ì‹œê°„ì„ ì ˆì•½**: ì „ë¬¸ê°€ê°€ ìƒë‹´ ì „ AI ë¦¬í¬íŠ¸ë¥¼ ë¯¸ë¦¬ ë°›ìœ¼ë¯€ë¡œ, ë” íš¨ìœ¨ì ì¸ ìƒë‹´ ê°€ëŠ¥ â†’ ì „ë¬¸ê°€ ë§Œì¡±ë„ â†‘

---

> **ì‹œì‘ í¬ì¸íŠ¸**: Phase 0 â†’ Phase 1 â†’ Phase 2 ìˆœì„œë¡œ ì§„í–‰.
> Phase 2ì—ì„œ ì—ì´ì „íŠ¸ 1ëª…ì´ë¼ë„ end-to-endë¡œ ëŒì•„ê°€ëŠ” ê²ƒì„ ë¨¼ì € í™•ì¸í•œ í›„
> ë©€í‹°ì—ì´ì „íŠ¸ë¡œ í™•ì¥í•˜ëŠ” ê²ƒì´ ë¦¬ìŠ¤í¬ë¥¼ ì¤„ì´ëŠ” í•µì‹¬ì…ë‹ˆë‹¤.
> ì „ë¬¸ê°€ ì—°ê²°ì€ Phase 5ì—ì„œ ë¶™ì´ë˜, ì´ˆê¸°ì—ëŠ” ìˆ˜ë™ìœ¼ë¡œ ì „ë¬¸ê°€ 3-5ëª…ë§Œ 
> ì§ì ‘ ì„­ì™¸í•´ì„œ í”„ë¡œí•„ì„ ë“±ë¡í•˜ëŠ” ê²ƒìœ¼ë¡œ ì‹œì‘í•˜ì„¸ìš”.
